GH Research (GHRS) Other Operating Expenses (2022 - 2024)
GH Research's (GHRS) quarterly Other Operating Expenses came in at $3.9 million in Q1 2024, up 845.56% year-on-year from $408435.3 in Q2 2023, and up 845.56% quarter-over-quarter from -$518000.0 in Q1 2023.
GH Research (GHRS) Other Operating Expenses (2022 - 2024) Analysis & Trends
GH Research's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $3.9 million for Q1 2024.
- On a quarterly basis, Other Operating Expenses rose 845.56% year-over-year to $3.9 million in Q1 2024; TTM through Dec 2024 was $3.9 million, a 845.56% increase from a year earlier, with the FY2025 full-year figure at $121.1 million, up 20.74% from the prior year.
- Other Operating Expenses climbed to $3.9 million in Q1 2024 per GHRS's latest filing, from -$518000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $3.9 million in Q1 2024 and bottomed at -$518000.0 in Q1 2023.
- The 3-year median for Other Operating Expenses is $2.2 million (2022), against an average of $1.9 million.
- Across the five-year window, Other Operating Expenses slumped 123.09% in 2023 and surged 845.56% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at $2.2 million in 2022, then slumped by 123.09% to -$518000.0 in 2023, then jumped by 845.56% to $3.9 million in 2024.
- Per Business Quant, the three latest GHRS Other Operating Expenses figures stand at $3.9 million (Q1 2024), -$518000.0 (Q1 2023), and $2.2 million (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | GH Research | 1.65 Bn | 1.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2023 | -518,000.00 |
| Mar 31, 2022 | 2.24 Mn |